Jörg Petersen

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆

Bettina Werle–Lapostolle, Scott Bowden, Stephen Locarnini et al. · Gastroenterology · 2004 · 899 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

A global scientific strategy to cure hepatitis B

Peter Revill, Francis V. Chisari, Joan M. Block et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 495 citations · Full text

Pharmacy, Biomedical Sciences, Infectious Diseases +14

Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues

Florian van Bömmel, Robert A. de Man, Heiner Wedemeyer et al. · Hepatology · 2009 · 330 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus

Tassilo Volz, Lena Allweiss, Mounira Ben ḾBarek et al. · Journal of Hepatology · 2012 · 318 citations

Life Sciences, Infectious Diseases, Pharmacology +12

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Thomas Berg, Karl‐Georg Simon, Stefan Mauss et al. · Journal of Hepatology · 2017 · 313 citations

Pharmacy, Pharmacology, Pharmacotherapy +4